7,601.18

-119.21

-1.54%

51,963.46

-379.10

-0.72%

25,536.17

-648.55

-2.48%

2,809.64

-49.58

-1.73%

4.9490

-0.0400

-0.80%

19.94

+2.74

+15.94%

3,906.70

-124.70

-3.09%

77,537.34

-4,161.20

-5.09%

Crude Oil Dec 26

104.10

+2.10

+2.06%

US Private Equity

10,932.82

-7.68

-0.07%

NasdaqCM - Nasdaq Real Time Price USD

Xilio Therapeutics, Inc. (XLO)

7.80 -0.13 (-1.64%)

As of 11:31:41 AM EDT. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC

GlobeNewswire 4d ago

XLO
-1.64%
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 27d ago

XLO
-1.64%
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 1mo ago

XLO
-1.64%
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

GlobeNewswire 2mo ago

XLO
-1.64%
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 3mo ago

XLO
-1.64%
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer

GlobeNewswire 3mo ago

XLO
-1.64%
Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates

Zacks 5mo ago

XLO
-1.64%
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates

GlobeNewswire 5mo ago

XLO
-1.64%
ABBV
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 5mo ago

XLO
-1.64%
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

GlobeNewswire 6mo ago

XLO
-1.64%
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

GlobeNewswire 6mo ago

XLO
-1.64%
ANIK
Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?

Zacks 6mo ago

XLO
-1.64%

Performance Overview

Return	XLO	S&P 500 (^GSPC)
YTD	-21.32%	+11.09%
1-Year	-37.37%	+11.47%
3-Year	-76.02%	+82.51%

Mobilize your Website

View Site in Mobile | Classic

Share by: